{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:16Z","timestamp":1772119396796,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tetrahydroisoquinolines (TIQs) such as salsolinol (SAL), norsalsolinol (NSAL) and their methylated derivatives N-methyl-norsalsolinol (NMNSAL) and\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-salsolinol (NMSAL), modulate dopaminergic neurotransmission and metabolism in the central nervous system. Dopaminergic neurotransmission is thought to play an important role in the pathophysiology of chronic tic disorders, such as Tourette syndrome (TS). Therefore, the urinary concentrations of these TIQ derivatives were measured in patients with TS and patients with comorbid attention-deficit\/hyperactivity disorder (TS\u2009+\u2009ADHD) compared with controls. Seventeen patients with TS, 12 with TS and ADHD, and 19 age-matched healthy controls with no medication took part in this study. Free levels of NSAL, NMNSAL, SAL, and NMSAL in urine were measured by a two-phase chromatographic approach. Furthermore, individual TIQ concentrations in TS patients were used in receiver-operating characteristics (ROC) curve analysis to examine the diagnostic value. NSAL concentrations were elevated significantly in TS [434.67\u2009\u00b1\u200955.4\u00a0nmol\/l (standard error of mean\u2009=\u2009S.E.M.), two-way ANOVA,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001] and TS\u2009+\u2009ADHD patients [605.18\u2009\u00b1\u2009170.21\u00a0nmol\/l (S.E.M.), two-way ANOVA,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001] compared with controls [107.02\u2009\u00b1\u200933.18\u00a0nmol\/l (S.E.M.), two-way ANOVA,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001] and NSAL levels in TS\u2009+\u2009ADHD patients were elevated significantly in comparison with TS patients (two-way ANOVA,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.017). NSAL demonstrated an AUC of 0.93\u2009\u00b1\u20090.046 (S.E.M) the highest diagnostic value of all metabolites for the diagnosis of TS. Our results suggest a dopaminergic hyperactivity underlying the pathophysiology of TS and ADHD. In addition, NSAL concentrations in urine may be a potential diagnostic biomarker of TS.\n                  <\/jats:p>","DOI":"10.1007\/s00702-020-02289-6","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T03:02:33Z","timestamp":1608692553000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-3659","authenticated-orcid":false,"given":"Philipp","family":"Capetian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Korte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Walitza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Taurines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"2289_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Philadelphia","edition":"5"},{"key":"2289_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.neuint.2013.09.016","volume":"63","author":"GD Briggs","year":"2013","unstructured":"Briggs GD, Nagy GM, Dickson PW (2013) Mechanism of action of salsolinol on tyrosine hydroxylase. Neurochem Int 63:726\u2013731. https:\/\/doi.org\/10.1016\/j.neuint.2013.09.016","journal-title":"Neurochem Int"},{"key":"2289_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaac.2015.06.011","volume":"54","author":"SC Cohen","year":"2015","unstructured":"Cohen SC, Mulqueen JM, Ferracioli-Oda E et al (2015) Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 54:728\u2013736. https:\/\/doi.org\/10.1016\/j.jaac.2015.06.011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2289_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00431-014-2417-0","volume":"174","author":"N El Malhany","year":"2015","unstructured":"El Malhany N, Gulisano M, Rizzo R, Curatolo P (2015) Tourette syndrome and comorbid ADHD: causes and consequences. Eur J Pediatr 174:279\u2013288. https:\/\/doi.org\/10.1007\/s00431-014-2417-0","journal-title":"Eur J Pediatr"},{"key":"2289_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/wnl.35.9.1346","volume":"35","author":"G Erenberg","year":"1985","unstructured":"Erenberg G, Cruse RP, Rothner AD (1985) Gilles de la Tourette\u2019s syndrome: effects of stimulant drugs. Neurology 35:1346\u20131348. https:\/\/doi.org\/10.1212\/wnl.35.9.1346","journal-title":"Neurology"},{"key":"2289_CR6","doi-asserted-by":"publisher","first-page":"13730","DOI":"10.1523\/JNEUROSCI.4172-09.2009","volume":"29","author":"H Ito","year":"2009","unstructured":"Ito H, Takano H, Takahashi H et al (2009) Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with l-[\u03b2-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission? J Neurosci 29:13730\u201313734. https:\/\/doi.org\/10.1523\/JNEUROSCI.4172-09.2009","journal-title":"J Neurosci"},{"key":"2289_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1176\/ajp.150.1.98","volume":"150","author":"JF Leckman","year":"1993","unstructured":"Leckman JF, Walker DE, Cohen DJ (1993) Premonitory urges in Tourette\u2019s syndrome. Am J Psychiatry 150:98\u2013102. https:\/\/doi.org\/10.1176\/ajp.150.1.98","journal-title":"Am J Psychiatry"},{"key":"2289_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.biopsych.2018.02.1172","volume":"84","author":"TV Maia","year":"2018","unstructured":"Maia TV, Concei\u00e7\u00e3o VA (2018) Dopaminergic disturbances in tourette syndrome: an integrative account. Biol Psychiatry 84:332\u2013344. https:\/\/doi.org\/10.1016\/j.biopsych.2018.02.1172","journal-title":"Biol Psychiatry"},{"key":"2289_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-4612-2000-8_2","volume-title":"Pharmacology of endogenous neurotoxins: a handbook","author":"A Moser","year":"1998","unstructured":"Moser A (1998a) TIQ derivatives in the human central nervous system. In: Moser A (ed) Pharmacology of endogenous neurotoxins: a handbook. Birkh\u00e4user, Boston, MA, pp 25\u201340"},{"key":"2289_CR10","doi-asserted-by":"crossref","unstructured":"Moser A (ed) (1998b) Pharmacology of Endogenous Neurotoxins: A Handbook. Birkh\u00e4user Basel","DOI":"10.1007\/978-1-4612-2000-8"},{"key":"2289_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0197-0186(95)00048-D","volume":"28","author":"A Moser","year":"1996","unstructured":"Moser A, Scholz J, Bamberg H, B\u00f6hme V (1996a) The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro. Neurochem Int 28:109\u2013112","journal-title":"Neurochem Int"},{"key":"2289_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF01276418","volume":"103","author":"A Moser","year":"1996","unstructured":"Moser A, Siebecker F, Vieregge P et al (1996b) Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson\u2019s disease. J Neural Transm Vienna Austria 103:421\u2013432. https:\/\/doi.org\/10.1007\/BF01276418","journal-title":"J Neural Transm Vienna Austria"},{"key":"2289_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.5607\/en.2019.28.5.602","volume":"28","author":"SH Park","year":"2019","unstructured":"Park SH, Song YS, Moon BS et al (2019) Combination of In Vivo [123I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum. Exp Neurobiol 28:602\u2013611. https:\/\/doi.org\/10.5607\/en.2019.28.5.602","journal-title":"Exp Neurobiol"},{"key":"2289_CR14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/mds.23053","volume":"25","author":"J Paszek","year":"2010","unstructured":"Paszek J, Pollok B, Biermann-Ruben K et al (2010) Is it a tic?\u2014Twenty seconds to make a diagnosis. Mov Disord 25:1106\u20131108. https:\/\/doi.org\/10.1002\/mds.23053","journal-title":"Mov Disord"},{"key":"2289_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim T, Holler-Managan Y, Okun MS et al (2019) Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92:907\u2013915. https:\/\/doi.org\/10.1212\/WNL.0000000000007467","journal-title":"Neurology"},{"key":"2289_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jpsychores.2008.03.006","volume":"65","author":"MM Robertson","year":"2008","unstructured":"Robertson MM (2008) The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 65:461\u2013472. https:\/\/doi.org\/10.1016\/j.jpsychores.2008.03.006","journal-title":"J Psychosom Res"},{"key":"2289_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1744-9081-3-64","volume":"3","author":"V Roessner","year":"2007","unstructured":"Roessner V, Walitza S, Riederer F et al (2007) Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD? Behav Brain Funct BBF 3:64. https:\/\/doi.org\/10.1186\/1744-9081-3-64","journal-title":"Behav Brain Funct BBF"},{"key":"2289_CR18","unstructured":"World Health Organization, Staff WHO (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization"},{"key":"2289_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1124\/jpet.111.186833","volume":"341","author":"G Xie","year":"2012","unstructured":"Xie G, Hip\u00f3lito L, Zuo W et al (2012) Salsolinol Stimulates Dopamine Neurons in Slices of Posterior Ventral Tegmental Area Indirectly by Activating \u03bc-Opioid Receptors. J Pharmacol Exp Ther 341:43\u201350. https:\/\/doi.org\/10.1124\/jpet.111.186833","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-020-02289-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T03:07:23Z","timestamp":1611025643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-020-02289-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1007\/s00702-020-02289-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740631415.793587891","asserted-by":"object"}]},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"The ethics committees of the participating universities gave full approval to the study protocol (Nr. 51\/02).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients, healthy controls and (if applicable) their legal guardians gave informed and written consent to participate in this study and for the publication of data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}